LOSS PER SHARE

9 Months Ended

Apr. 30, 2022

The following table reconciles loss per share for the three and nine months ended April 30, 2022 and 2021:


	Three Months Ended April 30,				Nine Months Ended April 30,
	2022		2021		2022		2021
	(In thousands, except per share data)
Reconciliation of net income (loss) to net income (loss) attributable to common stockholders after assumed conversions:
Net income (loss)	$	30,200	$	(27,629)	$	(12,271)	$	(33,376)
Less: Preferred dividends on redeemable preferred stock	(537)		(519)		(1,611)		(1,586)
Net income (loss) attributable to common stockholders	29,663		(28,148)		(13,882)		(34,962)





Net income (loss) attributable to common stockholders:
Continuing operations, net of tax	$	(10,232)	$	(9,813)	$	(13,774)	$	(13,067)
Discontinued operations, net of tax	39,895		(18,335)		(108)		(21,895)
Net income (loss) attributable to common stockholders	$	29,663	$	(28,148)	$	(13,882)	$	(34,962)






Weighted average common shares outstanding	59,853		62,263		59,961		61,898


Basic and diluted net income (loss) per share attributable to common stockholders:
Continuing operations	$	(0.17)	$	(0.16)	$	(0.23)	$	(0.21)
Discontinued operations, net of tax	$	0.67	$	(0.29)	$	—	$	(0.35)
Net income (loss) attributable to common stockholders	$	0.50	$	(0.45)	$	(0.23)	$	(0.56)

Basic net loss per common share is calculated using the weighted average number of common shares outstanding during the period. Diluted net earnings per common share, if any, gives effect to diluted stock options (calculated based on the treasury stock method), non-vested restricted stock shares purchased under the employee stock purchase plan and shares issuable upon debt or preferred stock conversion (calculated using an as-if converted method).

For the three months ended April 30, 2022, approximately 24.2 million common stock equivalent shares (including those related to convertible debt and preferred stock) were excluded from the denominator in the calculation of diluted net loss per share as their inclusion would have been antidilutive. For three months ended April 30, 2021, approximately 24.2 million common stock equivalent shares (including those related to convertible debt and preferred stock) were excluded from the denominator in the calculation of diluted net loss per share as their inclusion would have been antidilutive.

For each of the nine months ended April 30, 2022 and 2021, approximately 24.2 million and 24.3 million, respectively, common stock equivalent shares (including those related to convertible debt and preferred stock) were excluded from the denominator in the calculation of diluted net loss per share as their inclusion would have been antidilutive.